Lara Smith-Weber
Fortune : 16 120 $ au 31/05/2026
Fortune : 16 120 $ au 31/05/2026
Lara Smith-Weber is currently Chief Financial Officer at Fractyl Health, Inc. since 2026.
Former positions include Senior VP-Controlling & Internal Controlling at MorphoSys AG, Chief Financial Officer at Inari Amertron Bhd., Chief Financial Officer at ONWARD Medical NV, Head-Financial Planning & Analysis at MorphoSys US, Inc., and President, Secretary & Treasurer at Constellation Pharmaceuticals, Inc. Education includes undergraduate and graduate degrees from Stanford University and an MBA from the International Institute for Management Development.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FRACTYL HEALTH, INC. 0,01% | 08/06/2026 | 20 000 ( 0,01% ) | 16 120 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FRACTYL HEALTH, INC. | Directeur Financier/CFO | 12/01/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| ONWARD MEDICAL N.V. | Directeur Financier/CFO | 01/10/2023 |
| INARI AMERTRON | Directeur Financier/CFO | - |
MorphoSys US, Inc. | Corporate Officer/Principal | - |
| CONSTELLATION PHARMACEUTICALS, INC. | President | - |
| MORPHOSYS AG | Comptroller/Controller/Auditor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Inari Amertron Bhd.
Inari Amertron Bhd. SemiconductorsElectronic Technology Operates as an investment holding company with interest in manufacturing semiconductors and other electronics components | Electronic Technology |
Fractyl Health, Inc.
Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes and obesity | Health Technology |
GTX medical BV
GTX medical BV Medical SpecialtiesHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
MorphoSys US, Inc. | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national